These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 36155216)
1. Salvianolic acid B suppresses hepatic stellate cell activation and liver fibrosis by inhibiting the NF-κB signaling pathway via miR-6499-3p/LncRNA-ROR. Wang R; Li S; Chen P; Yue X; Wang S; Gu Y; Yuan Y Phytomedicine; 2022 Dec; 107():154435. PubMed ID: 36155216 [TBL] [Abstract][Full Text] [Related]
2. LincRNA-p21 Inhibits the Wnt/β-Catenin Pathway in Activated Hepatic Stellate Cells via Sponging MicroRNA-17-5p. Yu F; Guo Y; Chen B; Shi L; Dong P; Zhou M; Zheng J Cell Physiol Biochem; 2017; 41(5):1970-1980. PubMed ID: 28391277 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway. Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis. Feng Y; Li Y; Xu M; Meng H; Dai C; Yao Z; Lin N Stem Cell Res Ther; 2022 Jul; 13(1):375. PubMed ID: 35902883 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis. Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809 [TBL] [Abstract][Full Text] [Related]
6. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling. Wu SM; Li TH; Yun H; Ai HW; Zhang KH Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340 [TBL] [Abstract][Full Text] [Related]
7. lncRNA GAS5 restrains CCl Dong Z; Li S; Wang X; Si L; Ma R; Bao L; Bo A Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G539-G550. PubMed ID: 30735452 [TBL] [Abstract][Full Text] [Related]
8. A lncRNA Gpr137b-ps/miR-200a-3p/CXCL14 axis modulates hepatic stellate cell (HSC) activation. Liao J; Zhang Z; Yuan Q; Liu Q; Kuang J; Fang Y; Hu X Toxicol Lett; 2021 Jan; 336():21-31. PubMed ID: 33069761 [TBL] [Abstract][Full Text] [Related]
9. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis. Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413 [TBL] [Abstract][Full Text] [Related]
10. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis. Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141 [TBL] [Abstract][Full Text] [Related]
11. Prediction and verification of target of helenalin against hepatic stellate cell activation based on miR-200a-mediated PI3K/Akt and NF-κB pathways. Fang B; Wen S; Li Y; Bai F; Wei Y; Xiong Y; Huang Q; Lin X Int Immunopharmacol; 2021 Mar; 92():107208. PubMed ID: 33444919 [TBL] [Abstract][Full Text] [Related]
12. Identification lncRNA LOC102551149/miR-23a-5p pathway in hepatic fibrosis. Dong Z; Li S; Si L; Ma R; Bao L; Bo A Eur J Clin Invest; 2020 Jun; 50(6):e13243. PubMed ID: 32306379 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA GAS5 inhibits LX-2 cells activation by suppressing NF-κB signalling through regulation of the miR-433-3p/TLR10 axis. Su SB; Tao L; Liang XL; Chen W Dig Liver Dis; 2022 Aug; 54(8):1066-1075. PubMed ID: 34903500 [TBL] [Abstract][Full Text] [Related]
15. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways. Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378 [TBL] [Abstract][Full Text] [Related]
16. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling. Chen C; Chen J; Wang Y; Fang L; Guo C; Sang T; Peng H; Zhao Q; Chen S; Lin X; Wang X Phytomedicine; 2023 Feb; 110():154626. PubMed ID: 36603342 [TBL] [Abstract][Full Text] [Related]
17. miR-301a-3p promotes hepatic stellate cells activation and liver fibrogenesis via regulating PTEN/PDGFR-β. Chen X; Zhu S; Chen SY; Wang JN; Sun LJ; Tao SM; Li XF; Li HD; Sun YY; Xu CH; Suo XG; Ji ML; Huang C; Meng XM; Li J Int Immunopharmacol; 2022 Sep; 110():109034. PubMed ID: 35834952 [TBL] [Abstract][Full Text] [Related]
18. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis. Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis. Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103 [TBL] [Abstract][Full Text] [Related]
20. Salvianolic acid B inhibits hepatic stellate cell activation and liver fibrosis by targeting PDGFRβ. Liu F; Li S; Chen P; Gu Y; Wang S; Wang L; Chen C; Wang R; Yuan Y Int Immunopharmacol; 2023 Sep; 122():110550. PubMed ID: 37451016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]